The effect of L-thyroxine supplementation on retinal vascular development in neonatal rats

Current Eye Research

Volumn 30, Issue 12, 2005, Pages 1035-1040

  Mutapcic, Lejla ^a   Wren, Siobhan M E ^b   Leske, David A ^b   Fautsch, Michael P ^b   Holmes, Jonathan M ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b Mayo Clinic   (United States)

Author keywords

Insulin like growth factor 1; Retina; ROP; Thyroxine; Vasculogenesis

Indexed keywords

APYRASE; LEVOTHYROXINE; SODIUM CHLORIDE; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

AMBIENT AIR; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITY; DIGITALIZATION; DISSECTION; EYE FIXATION; FEMALE; HORMONAL THERAPY; IRRITABILITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RETINA BLOOD VESSEL; RETINA SURGERY; RETROLENTAL FIBROPLASIA; STAINING; SUPPLEMENTATION; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TREMOR;

ANIMALS; ANIMALS, NEWBORN; FEMALE; INJECTIONS, INTRAPERITONEAL; INSULIN-LIKE GROWTH FACTOR I; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VESSELS; THYROTROPIN; THYROXINE;

EID: 29144517812     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680500320711     Document Type: Article

References (31)

1. Fisher DA. Euthyroid low thyroxine (T4) and triiodothyronine (T3) states in prematures and sick neonates. Pediatr Clin North Am. 1990;37:1297-1312.
2. Bernal J, Nunez J. Thyroid hormones and brain development. Eur J Endocrinol. 1995;133:390-398.
3. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothroxinemia? J Clin Endocrinol Metab. 2000;85:3975-3987.
4. Dussault JH, Ruel J. Thyroid hormones and brain development. Annu Rev Physiol. 1987;49:321-334.
5. Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 1996;334:821-827.
6. Den Ouden AL, Kok JH, Verkerk PH, et al. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res. 1996;39:142-145.
7. Sevilla-Romero E, Munoz A, Pinazo-Duran MD. Low thyroid hormone levels impair the perinatal development of the rat retina. Ophthalmic Res. 2002;34:181-191.
8. Mookadam M, Leske DA, Fautsch MP, et al. The anti-thyroid drug methimazole induces neovascularization in the neonatal rat analogous to ROP. Invest Ophthalmol Vis Sci. 2004;45:4145-4150.
9. Berkowitz BA, Luan H, Roberts RL. Effect of methylimidazole-induced hypothyroidism in a model of low retinal neovascular incidence. Invest Ophthalmol Vis Sci. 2004;45:919-921.
10. Hellstrom A, Perruzzi C, Ju M, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA. 2001;98:5804-5808.
11. Hellstrom A, Engstrom E, Hard AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112:1016-1020.
12. Holmes JM, Duffner LA. The effect of litter size on normal retinal vascular development in the neonatal rat. Curr Eye Res. 1995;14:737-740.
13. Holmes JM, Duffner LA. The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat. Curr Eye Res. 1996;15:403-409.
14. Zhang S, Leske DA, Lanier WL, Holmes JM. Postnatal growth retardation exacerbates acidosis-induced retinopathy in the neonatal rat. Curr Eye Res. 2001;22:133-139.
15. Hornick P. A new method for giving repetitive intraperitoneal injections to neonatal rats. Lab Anim. 1986;20:14-15.
16. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest. 1995;96:2828-2838.
17. Yilmazer-Hanke DM, Hantsch M, Hanke J, et al. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats. Neuroscience. 2004;124:283-297.
18. Zhang S, Leske DA, Holmes JM. Neovascularization grading methods in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2000;41:887-891.
19. Lutty GA, McLeod DS. A new technique for visualization of the human retinal vasculature. Arch Ophthalmol. 1992;110:267-276.
20. Holmes JM, Zhang S, Leske DA, Lanier WL. The effect of carbon dioxide on oxygen-induced retinopathy in the neonatal rat. Curr Eye Res. 1997;16:725-732.
21. Holmes JM, Zhang S, Leske DA, Lanier WL. Carbon dioxide-induced retinopathy in the neonatal rat. Curr Eye Res. 1998;17:608-616.
22. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996;114:1219-1228.
23. Penn JS, Tolman BL, Henry MM. Oxygen induced retinopathy in the rat: relationship of retinal non perfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3429-3435.
24. Reynaud X, Dorey CK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci. 1994;35:3169-3177.
25. Dorey CK, Aouididi S, Reynaud X, et al. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 1996;114:1210-1217.
26. Miell JP, Taylor AM, Zini M, et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab. 1993;76:950-955.
27. Lakatos P, Foldes J, Nagy Z, et al. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. Thyroid. 2000;10:417-423.
28. Valcavi R, Dieguez C, Zini M, et al. Influence of hyperthyroidism on growth hormone secretion. Clin Endocrinol. 1993;38:515-522.
29. Miell JP, Zini M, Quin JD, et al. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy. J Clin Endocrinol Metab. 1994;79:1507-1512.
30. Angervo M, Toivonen J, Leinonen P, et al. Thyroxine withdrawal is accompanied by decreased circulating levels of insulin-like growth factor-binding protein-1 in thyroidectomized patients. J Clin Endocrinol Metab. 1993;76:1199-1201.
31. Vanhole C, Aerssens P, Naulaers G, et al. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res. 1997;42:87-92.